AnorMed Inc (AOM.TO) Buy, Sell or Hold

AnorMed Inc (AOM.TO)

0.00

-0.00 (0.00%)

1 watching

TOP PICK

Likes their product AMD-3100 which harvests bone marrow cells with remarkable effect prior to chemo therapy. Lots of cash. Has more upside and less risk than the average biotech.

DON'T BUY

When their cancer drug didn't meet expectations, their partner dropped out. Have a lot of cash, but there are better companies available.

BUY

One of the best 2/3 junior biotechs. Working on 3 products. Good partnerships.

TOP PICK

In phase 2 for aids, cancer drugs & phase 3 for a kidney failure drug. Big partners

TOP PICK

Has partnerships with leading global pharmaceuticals. Products are now in WAIT stage.

Showing 1 to 5 of 5 entries

AnorMed Inc (AOM.TO) Frequently Asked Questions

What is AnorMed Inc stock symbol?

AnorMed Inc is a OTC stock, trading under the symbol AOM.TO (previously AOM-T on Stockchase) on the undefined (undefined). It is usually referred to as or AOM.TO

Is AnorMed Inc a buy or a sell?

In the last year, no analyst issued a Buy, Sell, or Hold rating on AOM.TO (previously AOM-T on Stockchase) on Stockchase. Read the latest expert commentary for AnorMed Inc.

Is AnorMed Inc a good investment or a top pick?

AnorMed Inc was recommended as a Top Pick by Bruce Cooper on 2000-12-08. Read the latest stock experts ratings for AnorMed Inc.

Why is AnorMed Inc stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts' recommendations for AnorMed Inc.

Is AnorMed Inc worth watching?

AnorMed Inc is covered by Stockchase experts and is worth watching.

Most Recent Experts

Jim Lebenthal

Cerity Partners

Joe Terranova

Virtus Investment Partners

Rob Sechan, Managing Partner, New Edge Capital

New Edge Capital

Stephanie Link, Chief investment strategist, Hightower

Hightower

Larry Berman CFA, CMT, CTA

ETF Capital Management Inc.

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : [email protected].

AnorMed Inc (AOM.TO)